News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SCYNEXIS, Inc. Appoints Carole Sable, MD, As Chief Medical Officer


2/24/2014 6:44:30 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Drug discovery company SCYNEXIS, Inc., today announced that it has appointed infectious disease expert Carole Sable, MD, as Chief Medical Officer. Dr. Sable was most recently a Vice President at Merck & Co., Inc, initially as franchise integrator in Infectious Diseases and more recently as VP, Project Leadership and Management in Neurosciences and Ophthalmology.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES